SECRETORY IGA, INC.
Biotech · Private
Orally administered human secretory IgA (sIgA) immunotherapy for C. difficile infection, manufactured by combining plasma-derived dimeric IgA with recombinant human secretory component
- Grants
- $2.2M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Oral Immunotherapy with IgA to Treat Clostridium difficile Infection | $222,421 | |
| Federal grant | Department of Health and Human Services · Phase I · Oral Immunotherapy with IgA to Treat Clostridium difficile Infection | $46,681 | |
| Federal grant | Department of Health and Human Services · Phase II · Oral Immunotherapy with IgA to Treat C. difficile Infection | $892,325 | |
| Federal grant | Department of Health and Human Services · Phase II · Oral Immunotherapy with IgA to Treat C. difficile Infection | $1,020,531 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3181 | VectorY Therapeutics | — | — |
| 3182 | BIOMAGNETIC SOLUTIONS, LLC | — | — |
| 3183 | REVIVO THERAPEUTICS, INC. | — | — |
| 3184 | SECRETORY IGA, INC. | — | — |
| 3185 | JACARANDA BIOSCIENCES, INC. | — | — |
| 3186 | TenSixteen Bio | — | — |
| 3187 | PARTEK, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- TREATMENT OF ALLERGY WITH SECRETORY IgA ANTIGEN IMMUNE COMPLEXESapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.